BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36734588)

  • 1. P4HA1, transcriptionally activated by STAT1, promotes esophageal cancer progression.
    Gou W; Yang Y; Shan Q; Xia S; Ma Y
    Pathol Int; 2023 Apr; 73(4):147-158. PubMed ID: 36734588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-30e suppresses proliferation of hepatoma cells via targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) mRNA.
    Feng G; Shi H; Li J; Yang Z; Fang R; Ye L; Zhang W; Zhang X
    Biochem Biophys Res Commun; 2016 Apr; 472(3):516-22. PubMed ID: 26966067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-induced P4HA1 overexpression promotes post-ischemic angiogenesis by enhancing endothelial glycolysis through downregulating FBP1.
    Xu Y; Xia D; Huang K; Liang M
    J Transl Med; 2024 Jan; 22(1):74. PubMed ID: 38238754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.
    Chakravarthi BV; Pathi SS; Goswami MT; Cieślik M; Zheng H; Nallasivam S; Arekapudi SR; Jing X; Siddiqui J; Athanikar J; Carskadon SL; Lonigro RJ; Kunju LP; Chinnaiyan AM; Palanisamy N; Varambally S
    Oncotarget; 2014 Aug; 5(16):6654-69. PubMed ID: 25115393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multilevel chitosan-gelatin particles loaded with P4HA1 siRNA suppress glioma development.
    Zhou Y; Tian J; Zhu Y; Zhang Y; Zhao X
    Drug Deliv Transl Res; 2024 Mar; 14(3):665-677. PubMed ID: 37667088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Analysis of the Expression and Prognostic Significance of P4HA1 in Pancreatic Cancer and Construction of a lncRNA-miRNA-P4HA1 Regulatory Axis.
    Hu Z; Song F; Hu Y; Liao T
    Biomed Res Int; 2020; 2020():8877334. PubMed ID: 33415167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of P4HA1 inhibits neovascularization via targeting glioma stem cell-endothelial cell transdifferentiation and disrupting vascular basement membrane.
    Zhou Y; Jin G; Mi R; Zhang J; Zhang J; Xu H; Cheng S; Zhang Y; Song W; Liu F
    Oncotarget; 2017 May; 8(22):35877-35889. PubMed ID: 28415787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression.
    Li J; Ghazwani M; Zhang Y; Lu J; Li J; Fan J; Gandhi CR; Li S
    J Hepatol; 2013 Mar; 58(3):522-8. PubMed ID: 23178710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-124-3p inhibits collagen synthesis in atherosclerotic plaques by targeting prolyl 4-hydroxylase subunit alpha-1 (P4HA1) in vascular smooth muscle cells.
    Chen W; Yu F; Di M; Li M; Chen Y; Zhang Y; Liu X; Huang X; Zhang M
    Atherosclerosis; 2018 Oct; 277():98-107. PubMed ID: 30193190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P4HA1/HIF1α feedback loop drives the glycolytic and malignant phenotypes of pancreatic cancer.
    Cao XP; Cao Y; Li WJ; Zhang HH; Zhu ZM
    Biochem Biophys Res Commun; 2019 Aug; 516(3):606-612. PubMed ID: 31239153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas, and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls.
    Eriksson J; Le Joncour V; Jahkola T; Juteau S; Laakkonen P; Saksela O; Hölttä E
    Mol Oncol; 2020 Apr; 14(4):742-762. PubMed ID: 32053263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liraglutide protects high-glucose-stimulated fibroblasts by activating the CD36-JNK-AP1 pathway to downregulate P4HA1.
    Zhao T; Chen H; Cheng C; Zhang J; Yan Z; Kuang J; Kong F; Li C; Lu Q
    Biomed Pharmacother; 2019 Oct; 118():109224. PubMed ID: 31349139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT1 activation-induced apoptosis of esophageal squamous cell carcinoma cells in vivo.
    Kaganoi J; Watanabe G; Okabe M; Nagatani S; Kawabe A; Shimada Y; Imamura M; Sakai Y
    Ann Surg Oncol; 2007 Apr; 14(4):1405-15. PubMed ID: 17195908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT1/IFIT2 signaling pathway is involved in PD-L1-mediated epithelial-to-mesenchymal transition in human esophageal cancer.
    Chen J; Liu Y; Zhu Y; Chen Y; Feng J; Jiang T; Zheng X; Chen L; Jiang J
    Clin Transl Oncol; 2022 May; 24(5):927-940. PubMed ID: 35107757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT1-induced upregulation of lncRNA LINC01123 predicts poor prognosis and promotes the progression of endometrial cancer through miR-516b/KIF4A.
    Yang Y; Wu J; Zhou H; Liu W; Wang J; Zhang Q
    Cell Cycle; 2020 Jun; 19(12):1502-1516. PubMed ID: 32401659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of P4HA1 as a prognostic biomarker for high-grade gliomas.
    Hu WM; Zhang J; Sun SX; Xi SY; Chen ZJ; Jiang XB; Lin FH; Chen ZH; Chen YS; Wang J; Yang QY; Guo CC; Mou YG; Chen ZP; Zeng J; Sai K
    Pathol Res Pract; 2017 Nov; 213(11):1365-1369. PubMed ID: 28964577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent-free survival in head and neck squamous cell carcinoma.
    Li Q; Shen Z; Wu Z; Shen Y; Deng H; Zhou C; Liu H
    J Clin Lab Anal; 2020 Mar; 34(3):e23107. PubMed ID: 31782831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PHLDA3 activated by BARX2 transcription, suppresses the malignant development of esophageal squamous cell carcinoma by downregulating PI3K/AKT levels.
    Chen S; Lin X; He R; Zhang W; Kang M; Xu R
    Exp Cell Res; 2023 May; 426(2):113567. PubMed ID: 36965748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-122 inhibits epithelial mesenchymal transition by regulating P4HA1 in ovarian cancer cells.
    Duan Y; Dong Y; Dang R; Hu Z; Yang Y; Hu Y; Cheng J
    Cell Biol Int; 2018 Nov; 42(11):1564-1574. PubMed ID: 30136751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.